Hi-Tec, Magnum and Everyday California
brands to debut customized medically-directed CBD products in
2020
Apex Global Brands (NASDAQ:APEX), a global brand ownership and
marketing organization that manages, creates and elevates a growing
portfolio of high-equity lifestyle brands, and the new medical
division of Stem Holdings, Inc. (OTCQB:STMH)(CSE:STEM), a leading
vertically-integrated branded cannabis company with
state-of-the-art cultivation, processing, research and development,
extraction, retail, and distribution operations in the United
States, today announced a multi-brand partnership. Through this
partnership, the companies will debut customized medically-directed
CBD through licensing agreements with three of APEX's leading
brands.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20190919005391/en/
Stem Holdings has developed proprietary plant cultivars, each of
which is cultivated for the highest quality and efficacy. By
leveraging Apex Global Brands’ best-in-class brand portfolio,
retail distribution, and strong marketing platform, Stem Holdings
will be able to bring innovative products to market featuring these
proprietary strains. The custom product assortment has been
inspired by active consumers of three of APEX's brands, which
include:
- Hi-Tec® – a European-founded outdoor crossover brand offering
footwear, apparel and accessories since 1974;
- Magnum® – a global supplier of military, workwear and
service-industry footwear, apparel and accessories with a 37-year
legacy; and
- Everyday California® – a La Jolla, California based ocean,
adventure and lifestyle brand offering cool and casual apparel,
accessories and footwear.
Apex Global Brands regularly collaborates with companies around
the world within its portfolio of brands and has developed a
screening process for all potential partnerships that focuses on
innovation, quality, reputation and distribution.
“The selection process for a CBD partner was highly rigorous,"
said Henry Stupp, Chief Executive Officer of Apex Global Brands.
"We wanted to ensure that as we expanded into new types of
licensing agreements that the values of the prospective CBD
partner’s organization fit well with APEX's own values and
portfolio of brands. From the beginning of our discussions with
Stem, the fit and benefits this partnership could offer our common
consumers became more and more apparent. We cannot wait to share
some incredible and innovative products with consumers early next
year."
“We are proud to partner with Apex Global Brands to launch a
unique line of CBD products,” stated Adam Berk, Chief Executive
Officer of Stem Holdings. “Our medical division is collaborating
with Apex Global Brands' team to launch well-positioned products
that will deliver the benefits and values exemplified by the
Hi-Tec, Magnum and Everyday California brands, while also creating
new profit centers for their retailers across multiple channels. We
are seeing strong enthusiasm from both teams and know that our
combined experience will ensure that only the best-in-class CBD
products go to market.”
First product shipments are expected to take place in early
calendar year 2020.
About Apex Global Brands
Apex Global Brands is a global brand ownership and marketing
organization that manages, creates and elevates a growing portfolio
of high-equity lifestyle brands. The brand portfolio spans multiple
consumer product categories and retail tiers around the world and
includes Hi-Tec®, Magnum®, 50 Peaks®, Interceptor®, Cherokee®, Tony
Hawk®, Liz Lange®, Point Cove®, Carole Little®, Everyday
California® and Sideout®. The Company currently maintains license
agreements with leading retailers and manufacturers that span
approximately 140 countries in over 20,000 retail locations and
digital commerce. For more information, please visit the Company's
website at apexglobalbrands.com.
About Stem Holdings, Inc.
As a vertically-integrated cannabis company, Stem is as a
pioneer in the industry with its state-of-the-art cultivation,
processing, extraction, retail, and distribution operations. Stem
owns cannabis facilities in California, Nevada, Oklahoma, and
Oregon and hemp facilities in Pennsylvania and New York and also
participates in a research project in collaboration with Cornell
University. Utilizing proprietary, sustainable cultivation
techniques, Stem develops exceptional products that are safe and
consist of lab-tested cannabis and CBD. Stem’s owned and partner
consumer brands are award-winning and nationally known including
cultivators TJ's Gardens® and Yerba Buena®; retail banners Stem and
TJ's; infused product manufacturers, Cannavore™ and Supernatural
Honey™; and a new CBD company, Dose-ology™. Stem's mission in
supporting the health and happiness of people and the safety of our
planet is evident through the Company's continued recognition for
its community involvement, employee diversification, and its
designation as a top place to work in cannabis, as well as
dedication to environmental causes and outstanding leadership in
the cannabis industry. For more information, please visit the
Company's website at stemholdings.com.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION
This press release contains statements which constitute
“forward-looking information” within the meaning of applicable
securities laws, including statements regarding the plans,
intentions, beliefs and current expectations of the management of
Stem with respect to future business activities. Forward-looking
information is often identified by the words “may,” “would,”
“could,” “should,” “will,” “intend,” “plan,” “anticipate,”
“believe,” “estimate,” “expect” or similar expressions and include
information regarding: (i) the ability of the Company to
successfully achieve its business objectives, (ii) the expected
curated product portfolio (iii) plans for Stem and the expected
date of first product shipments (iv) expectations for other
economic, business, and/or competitive factors, and (v) anticipated
growth of Stem.
Investors are cautioned that forward-looking information is not
based on historical facts but instead reflect the management of
Stem’s expectations, estimates or projections concerning future
results or events based on the opinions, assumptions and estimates
of management considered reasonable at the date the statements are
made. Although Stem believes that the expectations reflected in
such forward-looking information are reasonable, such information
involves risks and uncertainties, and undue reliance should not be
placed on such information, as unknown or unpredictable factors
could have material adverse effects on future results, performance
or achievements of the Company. Among the key factors that could
cause actual results to differ materially from those projected in
the forward-looking information are the following: changes in
general economic, business and political conditions, including
changes in the financial markets; the ability of the Company to
raise debt and equity capital in the amounts and at the costs that
it expects; adverse changes in the public perception of cannabis;
decreases in the prevailing prices for cannabis and cannabis
products in the markets that the Company operates in; adverse
changes in applicable laws; or adverse changes in the application
or enforcement of current laws, including those related to
taxation; the inability to locate and acquire suitable companies,
properties and assets necessary to execute on the Company’s
business plans; and increasing costs of compliance with extensive
government regulation. This forward-looking information may be
affected by risks and uncertainties in the business of Stem and
market conditions.
Should one or more of these risks or uncertainties materialize,
or should assumptions underlying the forward-looking information
prove incorrect, actual results may vary materially from those
described herein as intended, planned, anticipated, believed,
estimated or expected. Although Stem has attempted to identify
important risks, uncertainties and factors which could cause actual
results to differ materially, there may be others that cause
results not to be as anticipated, estimated or intended. Stem does
not intend, and does not assume any obligation, to update this
forward-looking information except as otherwise required by
applicable law.
No securities regulatory authority has in any way passed upon
the merits of the proposed transactions described in this news
release or has approved or disapproved of the contents of this news
release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190919005391/en/
For Apex Global Brands:
Media Relations: Apex Global Brands Nadine Iacocca, VP
Global Marketing nadinei@apex-gb.com
Investor Relations: Addo Investor Relations Kimberly
Esterkin, Patricia Nir kesterkin@addoir.com; pnir@addoir.com
For Stem Holdings:
Media Relations: Mauria Betts Director of Branding and Public
Relations mauria@stemholdings.com
Investor Relations: John Mills ICR, LLC
john.mills@ICRinc.com
Apex Global Brands (NASDAQ:APEX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Apex Global Brands (NASDAQ:APEX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024